|
1
|
Baggott CD and Aagaard-Kienitz B: Cerebral
vasospasm. Neurosurg Clin N Am. 25:497–528. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nishizawa S and Laher I: Signaling
mechanisms in cerebral vasospasm. Trends Cardiovasc Med. 15:24–34.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pluta RM: Delayed cerebral vasospasm and
nitric oxide: Review, new hypothesis and proposed treatment.
Pharmacol Ther. 105:23–56. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sehba FA and Bederson JB: Mechanisms of
acute brain injury after subarachnoid hemorrhage. Neurol Res.
28:381–398. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Suhardja A: Mechanisms of disease: Roles
of nitric oxide and endothelin-1 in delayed cerebral vasospasm
produced by aneurysmal subarachnoid hemorrhage. Nat Clin Pract
Cardiovasc Med. 1:110–116; quiz 2 p following 116. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cunningham LA, Wetzel M and Rosenberg GA:
Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia.
50:329–339. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fatar M, Stroick M, Griebe M and Hennerici
M: Matrix metalloproteinases in cerebrovascular diseases.
Cerebrovasc Dis. 20:141–151. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rosenberg GA: Matrix metalloproteinases in
neuroinflammation. Glia. 39:279–291. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Z, Fang Q, Dang BQ, Shen XM, Shu Z,
Zuo G, He WC and Chen G: Potential contribution of matrix
metalloproteinase-9 (mmp-9) to cerebral vasospasm after
experimental subarachnoid hemorrhage in rats. Ann Clin Lab Sci.
42:14–20. 2012.PubMed/NCBI
|
|
10
|
Choudhri TF, Hoh BL, Solomon RA, Connolly
ES Jr and Pinsky DJ: Use of a spectrophotometric hemoglobin assay
to objectively quantify intracerebral hemorrhage in mice. Stroke.
28:2296–2302. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Humphrey JD, Baek S and Niklason LE:
Biochemomechanics of cerebral vasospasm and its resolution: I. A
new hypothesis and theoretical framework. Ann Biomed Eng.
35:1485–1497. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim JH, Yi HJ, Ko Y, Kim YS, Kim DW and
Kim JM: Effectiveness of papaverine cisternal irrigation for
cerebral vasospasm after aneurysmal subarachnoid hemorrhage and
measurement of biomarkers. Neurol Sci. 35:715–722. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kasuya H, Onda H, Takeshita M, Okada Y and
Hori T: Efficacy and safety of nicardipine prolonged-release
implants for preventing vasospasm in humans. Stroke. 33:1011–1015.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nishiguchi M, Ono S, Iseda K, Manabe H,
Hishikawa T and Date I: Effect of vasodilation by milrinone, a
phosphodiesterase III inhibitor, on vasospastic arteries after a
subarachnoid hemorrhage in vitro and in vivo: Effectiveness of
cisternal injection of milrinone. Neurosurgery. 66:158–164;
discussion 164. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Macdonald RL, Higashida RT, Keller E,
Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A,
et al: Randomized trial of clazosentan in patients with aneurysmal
subarachnoid hemorrhage undergoing endovascular coiling. Stroke.
43:1463–1469. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Y, Clark JF, Pyne-Geithman G and
Caruso J: Metallomics study in CSF for putative biomarkers to
predict cerebral vasospasm. Metallomics. 2:628–637. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Horstmann S, Su Y, Koziol J,
Meyding-Lamadé U, Nagel S and Wagner S: MMP-2 and MMP-9 levels in
peripheral blood after subarachnoid hemorrhage. J Neurol Sci.
251:82–86. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rosell A, Ortega-Aznar A, Alvarez-Sabín J,
Fernández-Cadenas I, Ribó M, Molina CA, Lo EH and Montaner J:
Increased brain expression of matrix metalloproteinase-9 after
ischemic and hemorrhagic human stroke. Stroke. 37:1399–1406. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sarrafzadeh A, Copin JC, Bengualid DJ,
Turck N, Vajkoczy P, Bijlenga P, Schaller K and Gasche Y: Matrix
metalloproteinase-9 concentration in the cerebral extracellular
fluid of patients during the acute phase of aneurysmal subarachnoid
hemorrhage. Neurol Res. 34:455–461. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chou SH, Feske SK, Simmons SL, Konigsberg
RG, Orzell SC, Marckmann A, Bourget G, Bauer DJ, De Jager PL, Du R,
et al: Elevated peripheral neutrophils and matrix metalloproteinase
9 as biomarkers of functional outcome following subarachnoid
hemorrhage. Transl Stroke Res. 2:600–607. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
McGirt MJ, Lynch JR, Blessing R, Warner
DS, Friedman AH and Laskowitz DT: Serum von Willebrand factor,
matrix metalloproteinase-9, and vascular endothelial growth factor
levels predict the onset of cerebral vasospasm after aneurysmal
subarachnoid hemorrhage. Neurosurgery. 51:1128–1134; discussion
1134–1135. 2002. View Article : Google Scholar : PubMed/NCBI
|
